- Home
- TAK vs DB Comparison
TAK vs DB Comparison
Compare TAK & DB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- DB
- Stock Information
- Founded
- TAK 1781
- DB 1870
- Country
- TAK Japan
- DB Germany
- Employees
- TAK N/A
- DB N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- DB Major Banks
- Sector
- TAK Health Care
- DB Finance
- Exchange
- TAK Nasdaq
- DB Nasdaq
- Market Cap
- TAK 42.2B
- DB 47.0B
- IPO Year
- TAK N/A
- DB N/A
- Fundamental
- Price
- TAK $14.71
- DB $23.47
- Analyst Decision
- TAK
- DB Buy
- Analyst Count
- TAK 0
- DB 1
- Target Price
- TAK N/A
- DB N/A
- AVG Volume (30 Days)
- TAK 2.5M
- DB 4.6M
- Earning Date
- TAK 05-08-2025
- DB 04-29-2025
- Dividend Yield
- TAK 4.01%
- DB 3.29%
- EPS Growth
- TAK 15.39
- DB N/A
- EPS
- TAK 0.83
- DB 1.42
- Revenue
- TAK $29,124,927,177.00
- DB $29,260,793,052.00
- Revenue This Year
- TAK $8.53
- DB $11.79
- Revenue Next Year
- TAK N/A
- DB $2.62
- P/E Ratio
- TAK $34.69
- DB $15.83
- Revenue Growth
- TAK 9.83
- DB 3.24
- 52 Week Low
- TAK $12.58
- DB $13.70
- 52 Week High
- TAK $15.37
- DB $25.33
- Technical
- Relative Strength Index (RSI)
- TAK 52.69
- DB 54.38
- Support Level
- TAK $13.60
- DB $23.18
- Resistance Level
- TAK $15.37
- DB $23.66
- Average True Range (ATR)
- TAK 0.33
- DB 0.89
- MACD
- TAK -0.03
- DB 0.05
- Stochastic Oscillator
- TAK 62.71
- DB 82.08
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About DB Deutsche Bank AG
Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.